2 Jun 2011

On 31 May 2011 Yungjin Pharm.’s asthma/COPD (Chronic obstructive pulmonary disease) medication development task was selected as “Ministry of Knowledge Economy, futurity industry leading technology enterprise”

Existing asthma/COPD medication is used to relieve symptoms for management purpose. If this task is successfully implemented and products are successfully released for treatment of asthma and chronic obstructive pulmonary disease, then it will be a groundbreaking new drug product of natural substance with relatively few adverse events.